Open access
Open access
Powered by Google Translator Translator

RCT: Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis.

10 Mar, 2022 | 10:27h | UTC

Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial – The Lancet Rheumatology (link to abstract – $ for full-text)

Commentary: COMPLETE-PsA: Adding leflunomide to methotrexate may improve outcomes – medwireNews

 

Commentary on Twitter

 


Stay Updated in Your Specialty

No spam, just news.